idoxuridine has been researched along with Adenocarcinoma in 33 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To detect and quantify hypoxia in colorectal adenocarcinomas by use of pimonidazole and iododeoxyuridine (IdUrd) as extrinsic markers and carbonic anhydrase IX (CA IX), microvessel density (MVD), epidermal growth-factor receptor (EGFR), and vascular endothelial growth factor (VEGF) as intrinsic markers of hypoxia." | 3.73 | Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. ( Begg, AC; De Schutter, H; Debucquoy, A; Ectors, N; Geboes, K; Goethals, L; Haustermans, KM; McBride, WH; Penninckx, F; Perneel, C, 2006) |
| " The extent of control of the EMT-6 mammary adenocarcinoma was determined using fractionated radiation (12 irradiations) over a 3-week period using the radiosensitizer 5-chloro-2'-deoxycytidine (CldC) and biomodulators of its metabolism: N-(Phosphonacetyl)-L-aspartate (PALA), tetrahydrouridine and 5-fluoro-2'-deoxycytidine (FdC)." | 3.69 | Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation. ( Greer, S; Marion, HS; Schwade, J, 1995) |
| "Seven patients with colorectal adenocarcinoma and one with squamous cell carcinoma of anorectal region were infused preoperatively with iododeoxyuridine (IUdR) and bromodeoxyuridine (BrdU) in sequence (100 mg/m2 x 1 hr each with 1-hr interval in between) to label S-phase cells." | 3.68 | Cell cycle parameters and DNA ploidy in colorectal carcinomas. ( Bokhari, J; Hyams, D; Khan, S; Raza, A; Sheikh, Y; Yousuf, N, 1991) |
| "Reutilization of thymidine (TdR) and 5-iodo-2'-deoxyuridine (I-UdR) released by dying tumour cells was assayed in the syngeneic adenocarcinoma EO 771 by injecting heat killed, labelled tumour cells into tumours." | 3.67 | Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique. ( Feinendegen, LE; Mühlensiepen, H; Porschen, R; Porschen, W, 1987) |
| "Ten patients with colorectal cancer were injected intratumorally with [125I]UdR) (0." | 1.29 | Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. ( Baranowska-Kortylewicz, J; Cei, A; Collecchi, P; Di Luca, L; Di Sacco, S; Di Stefano, R; Ferdeghini, EM; Mariani, G; Van den Abbeele, AD; Viacava, P, 1993) |
| "Warfarin inhibits metastasis in the animal model and injection of the Warfarin-dependent coagulation factor complex II, IX, X enhances pulmonary metastasis in the same model." | 1.28 | Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved. ( George, WD; McCulloch, P; Purushotham, AD, 1991) |
| " It is concluded that in situ evaluation of tumour activity loss rates in carcinoma EO 771 is not disturbed by toxic effects of I-UdR or 125I-UdR within the dose limits mentioned." | 1.27 | Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival. ( Feinendegen, LE; Mühlensiepen, H; Porschen, R; Porschen, W, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (42.42) | 18.7374 |
| 1990's | 12 (36.36) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 1 (3.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Q | 1 |
| Nicholson, AM | 1 |
| Barr, H | 1 |
| Harrison, LA | 1 |
| Wilson, GD | 3 |
| Burkert, J | 1 |
| Jeffery, R | 1 |
| Alison, MR | 1 |
| Looijenga, L | 1 |
| Lin, WR | 1 |
| McDonald, SA | 1 |
| Wright, NA | 1 |
| Harrison, R | 1 |
| Peppelenbosch, MP | 1 |
| Jankowski, JA | 1 |
| CALABRESI, P | 1 |
| CREASEY, WA | 1 |
| PRUSOFF, H | 1 |
| WELCH, AD | 1 |
| CLIFTON, KH | 3 |
| SZYBALSKI, W | 1 |
| HEIDELBERGER, C | 1 |
| GOLLIN, FF | 1 |
| ANSFIELD, FJ | 1 |
| VERMUND, H | 1 |
| Chi, KH | 1 |
| Wang, HE | 1 |
| Wang, YS | 1 |
| Chou, SL | 1 |
| Yu, HM | 1 |
| Tseng, YH | 1 |
| Hwang, IM | 1 |
| Lui, WY | 1 |
| Baranowska-Kortylewicz, J | 2 |
| Nearman, J | 1 |
| Goethals, L | 1 |
| Debucquoy, A | 1 |
| Perneel, C | 1 |
| Geboes, K | 1 |
| Ectors, N | 1 |
| De Schutter, H | 1 |
| Penninckx, F | 1 |
| McBride, WH | 1 |
| Begg, AC | 1 |
| Haustermans, KM | 1 |
| Porschen, R | 4 |
| Porschen, W | 4 |
| Mühlensiepen, H | 4 |
| Feinendegen, LE | 4 |
| Hamilton, E | 1 |
| Dobbin, J | 1 |
| Greer, S | 1 |
| Schwade, J | 1 |
| Marion, HS | 1 |
| Wilson, MS | 3 |
| Anderson, E | 1 |
| Bell, JC | 1 |
| Pearson, JM | 1 |
| Haboubi, NY | 1 |
| James, RD | 3 |
| Schofield, PF | 3 |
| Yoshida, K | 1 |
| Fujikawa, T | 1 |
| Tanabe, A | 1 |
| Sakurai, K | 1 |
| Mariani, G | 1 |
| Cei, A | 1 |
| Collecchi, P | 1 |
| Van den Abbeele, AD | 1 |
| Di Luca, L | 1 |
| Di Stefano, R | 1 |
| Viacava, P | 1 |
| Ferdeghini, EM | 1 |
| Di Sacco, S | 1 |
| West, CM | 2 |
| Roberts, SA | 2 |
| Philip, PA | 1 |
| Kaklamanis, L | 1 |
| Carmichael, J | 1 |
| Tonkin, K | 1 |
| Morrison, H | 1 |
| Gatter, K | 1 |
| Harris, AL | 1 |
| Page, GG | 1 |
| Blakely, WP | 1 |
| Ben-Eliyahu, S | 1 |
| Yasui, L | 1 |
| Hughes, A | 1 |
| DeSombre, E | 1 |
| Mach, RH | 1 |
| Huang, Y | 1 |
| Buchheimer, N | 1 |
| Kuhner, R | 1 |
| Wu, L | 1 |
| Morton, TE | 1 |
| Wang, L | 1 |
| Ehrenkaufer, RL | 1 |
| Wallen, CA | 1 |
| Wheeler, KT | 1 |
| Riches, AC | 1 |
| Gore, D | 1 |
| Docherty, J | 1 |
| Littlewood, V | 1 |
| Fritze, D | 1 |
| Kern, DH | 2 |
| Drogemuller, CR | 1 |
| Pilch, YH | 2 |
| Hughes, AM | 1 |
| Calvin, M | 1 |
| Kelly, SA | 1 |
| Gschmeissner, S | 1 |
| East, N | 1 |
| Balkwill, FR | 1 |
| Purushotham, AD | 1 |
| McCulloch, P | 1 |
| George, WD | 1 |
| Yousuf, N | 1 |
| Khan, S | 1 |
| Sheikh, Y | 1 |
| Hyams, D | 1 |
| Bokhari, J | 1 |
| Raza, A | 1 |
| Bagshawe, KD | 2 |
| Sharma, K | 1 |
| Southall, PJ | 1 |
| Boden, JA | 1 |
| Boxer, GM | 1 |
| Patridge, TA | 1 |
| Antoniw, P | 1 |
| Pedley, RB | 1 |
| Humm, JL | 1 |
| Sharma, SK | 1 |
| Boxer, G | 1 |
| Bornschein, R | 1 |
| Kucera, LS | 1 |
| Simonson, J | 1 |
| Veltman, LL | 1 |
| Yatvin, MB | 2 |
| Crouse, DT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Epidural Anesthesia-analgesia on Long-term Survival in Patients After Lung Cancer Surgery: A Randomized Controlled Trial[NCT02801409] | 400 participants (Actual) | Interventional | 2015-05-25 | Completed | |||
| Impact of Perioperative Dexmedetomidine on Long-term Survival in Older Patients After Cancer Surgery: a Multicenter Randomized Trial[NCT06030804] | 4,532 participants (Anticipated) | Interventional | 2023-09-12 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
33 other studies available for idoxuridine and Adenocarcinoma
| Article | Year |
|---|---|
Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus.
Topics: Adenocarcinoma; Adult; Barrett Esophagus; Biopsy, Needle; Case-Control Studies; Cell Cycle; Cell Tra | 2013 |
Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine.
Topics: Adenocarcinoma; Bromodeoxycytidine; Carcinoma; Carcinoma, Squamous Cell; Deoxycytidine; Hodgkin Dise | 1963 |
INCORPORATION OF I-125-LABELED IODODEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF MURINE AND HUMAN TISSUES FOLLOWING THERAPEUTIC DOSES.
Topics: Adenocarcinoma; Animals; DNA; DNA, Neoplasm; Floxuridine; Geriatrics; Idoxuridine; Intestine, Small; | 1963 |
Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.
Topics: Adenocarcinoma; Animals; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; DNA, Antis | 2004 |
DNA uptake of 131I-iododeoxyuridine.
Topics: Adenocarcinoma; Animals; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; DNA, Antis | 2005 |
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Carbonic Anhydrase | 2006 |
Cell loss from viable and necrotic tumour regions measured by 125I-UdR.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Survival; Idoxuridine; Male; Mice; Mice, Inbred C57BL; | 1983 |
[3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
Topics: Adenocarcinoma; Animals; Cell Division; Deoxyuridine; DNA, Neoplasm; Female; Idoxuridine; Male; Mice | 1982 |
Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation.
Topics: Adenocarcinoma; Animals; Aspartic Acid; Body Weight; Deoxycytidine; Idoxuridine; Mammary Neoplasms, | 1995 |
An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Cell Division; Colorectal Neoplasms; Flow Cytometry; Humans; | 1994 |
Quantitative analysis of distribution and fate of human lung cancer emboli labeled with 125I-5-iodo-2'-deoxyuridine in nude mice.
Topics: Adenocarcinoma; Animals; Female; Humans; Idoxuridine; In Vitro Techniques; Iodine Radioisotopes; Iso | 1993 |
Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Autoradiography; Colorectal Neoplasms; Female; Humans; Idox | 1993 |
Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.
Topics: Adenocarcinoma; Biopsy; Cell Division; Colorectal Neoplasms; DNA, Neoplasm; Flow Cytometry; Humans; | 1993 |
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Biopsy, | 1993 |
An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.
Topics: Adenocarcinoma; Cell Cycle; Cell Division; Colorectal Neoplasms; DNA, Neoplasm; Flow Cytometry; Huma | 1993 |
Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.
Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Antiviral Agents; Bupivacaine; Expl | 2001 |
Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.
Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Antiviral Agents; Bupivacaine; Expl | 2001 |
Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.
Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Antiviral Agents; Bupivacaine; Expl | 2001 |
Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.
Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Antiviral Agents; Bupivacaine; Expl | 2001 |
Relative biological effectiveness of accumulated 125IdU and 125I-estrogen decays in estrogen receptor-expressing MCF-7 human breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Nucleus; Cell Survival; DNA Damage; DNA, Neoplasm; Dose-Respo | 2001 |
[[(18)F]N-(4'-fluorobenzyl)-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [(18)F]FDG, and [(125)I]IUDR.
Topics: Acetamides; Adenocarcinoma; Animals; Female; Fluorodeoxyglucose F18; Idoxuridine; Mammary Neoplasms, | 2001 |
The use of 5-(125I)iodo-2'-deoxyuridine for monitoring DNA synthesis in organ culture.
Topics: Adenocarcinoma; Animals; DNA; DNA, Neoplasm; Humans; Hydroxyurea; Idoxuridine; Iodine Radioisotopes; | 1976 |
A new micromethod for the detection of HL-A antigens on cultured human tumor cells.
Topics: Adenocarcinoma; Antibody Specificity; Colonic Neoplasms; Culture Techniques; Cytotoxicity Tests, Imm | 1975 |
Cytocidal effect of rifamycin derivatives on ascites tumor cells: studies with [125I]iododeoxyuridine.
Topics: Adenocarcinoma; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cell Survival; Female; Idoxuridine; Io | 1979 |
Enhancement of metastatic potential by gamma-interferon.
Topics: Adenocarcinoma; Animals; Antibodies; Cell Adhesion; Cell Division; Colonic Neoplasms; Extracellular | 1991 |
Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Cell Division; Factor IX; Factor X; Femal | 1991 |
Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Colorectal Neoplasms; DNA; | 1991 |
Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
Topics: Adenocarcinoma; Animals; Cell Line; Choriocarcinoma; Colon; Colonic Neoplasms; Cytarabine; Drug Resi | 1991 |
Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
Topics: Adenocarcinoma; Animals; Astatine; Bromine Radioisotopes; Cell Nucleus; Cell Survival; Choriocarcino | 1991 |
Cell loss from viable and necrotic tumor regions after local gamma irradiation measured by 125I-UdR.
Topics: Adenocarcinoma; Animals; DNA, Neoplasm; Gamma Rays; Idoxuridine; Iodine Radioisotopes; Male; Mammary | 1987 |
Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
Topics: Adenocarcinoma; Animals; Cell Survival; Idoxuridine; Iodine Radioisotopes; Male; Mammary Neoplasms, | 1987 |
Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
Topics: Adenocarcinoma; Animals; DNA, Neoplasm; Idoxuridine; Iodine Radioisotopes; Male; Mammary Neoplasms, | 1985 |
Isolation and characterization of a cell line from the cocultivation of Lucké renal tumor cells and nontransformed feeder cells.
Topics: Adenocarcinoma; Animals; Anterior Chamber; Anura; Bromodeoxyuridine; Cell Division; Cell Line; Cytop | 1974 |
Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
Topics: Adenocarcinoma; Animals; Cytotoxicity Tests, Immunologic; Humans; Idoxuridine; Iodine Radioisotopes; | 1974 |
Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
Topics: Adenocarcinoma; Animals; Cell Division; DNA, Neoplasm; Idoxuridine; Iodine Radioisotopes; Mammary Ne | 1970 |
Studies on the mechanism of the stimulatory effect of lethally irradiated cells on tumor inocula.
Topics: Adenocarcinoma; Animals; Cell Nucleus; Hindlimb; Idoxuridine; Iodine Isotopes; Male; Mammary Neoplas | 1970 |